Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Medlive Technology Co., Ltd. ( (HK:2192) ) has provided an announcement.
Medlive Technology Co., Ltd. reported a 28.2% increase in revenue for the first half of 2025 compared to the same period in 2024, driven primarily by its precision marketing and corporate solutions segment. The company’s financial performance highlights a 5.9% increase in profit attributable to owners, indicating a stable growth trajectory and reinforcing its strong market position in the healthcare technology sector.
The most recent analyst rating on (HK:2192) stock is a Buy with a HK$16.50 price target. To see the full list of analyst forecasts on Medlive Technology Co., Ltd. stock, see the HK:2192 Stock Forecast page.
More about Medlive Technology Co., Ltd.
Medlive Technology Co., Ltd. operates in the healthcare technology industry, providing precision marketing and corporate solutions, medical knowledge solutions, and intelligent patient management solutions. The company is focused on leveraging technology to enhance healthcare services and solutions.
Average Trading Volume: 3,479,797
Technical Sentiment Signal: Buy
Current Market Cap: HK$10.59B
For detailed information about 2192 stock, go to TipRanks’ Stock Analysis page.